Mikhail Berlov

Dr. Mikhail Berlov

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2018 in Marine Drugs
Verified
Journal Article
Open access
PDF file
EUEkaterina Umnyakova
Ekaterina Umnyakova
NGNikolay Gorbunov
Nikolay Gorbunov
AZAlexander V. Zhakhov
Alexander V. Zhakhov
IKIlia A. Krenev
Ilia A. Krenev
TOTatiana V. Ovchinnikova
Tatiana V. Ovchinnikova
Mikhail BerlovMikhail Berlov
Mikhail Berlov
Antimicrobial peptides from marine invertebrates are known not only to act like cytotoxic agents, but they also can display some additional activities in mammalian organisms. In particular, these peptides can modulate the complement system as was described for tachyplesin, a peptide from the horseshoe crab. In this work, we investigated the influence on complement activation of the antimicrobial peptide arenicin-1 from the marine polychaete Arenicola marina. To study effects of arenicin on complement activation in human blood serum, we used hemolytic assays of two types, with antibody sensitized sheep erythrocytes and rabbit erythrocytes. Complement activation was also assessed, by the level of C3a production that was measured by ELISA. We found that the effect of arenicin depends on its concentration. At relatively low concentrations the peptide stimulates complement activation and lysis of target erythrocytes, whereas at higher concentrations arenicin acts as a complement inhibitor. A hypothetical mechanism of peptide action is proposed, suggesting its interaction with two complement proteins, C1q and C3. The results lead to the possibility of the development of new approaches for therapy of diseases connected with complement dysregulation, using peptide regulators derived from natural antimicrobial peptides of invertebrates.

10 December 2020 in Marine Drugs
Verified
Journal Article
Open access
PDF file
IKIlia A. Krenev
Ilia A. Krenev
EUEkaterina Umnyakova
Ekaterina Umnyakova
IEIgor Eliseev
Igor Eliseev
YDYaroslav Dubrovskii
Yaroslav Dubrovskii
NGNikolay Gorbunov
Nikolay Gorbunov
Mikhail BerlovMikhail Berlov
Mikhail Berlov
Antimicrobial peptides (AMPs) are not only cytotoxic towards host pathogens or cancer cells but also are able to act as immunomodulators. It was shown that some human and non-human AMPs can interact with complement proteins and thereby modulate complement activity. Thus, AMPs could be considered as the base for complement-targeted therapeutics development. Arenicins from the sea polychaete Arenicola marina, the classical example of peptides with a β-hairpin structure stabilized by a disulfide bond, were shown earlier to be among the most prospective regulators. Here, we investigate the link between arenicins’ structure and their antimicrobial, hemolytic and complement-modulating activities using the derivative Ar-1-(C/A) without a disulfide bond. Despite the absence of this bond, the peptide retains all important functional activities and also appears less hemolytic in comparison with the natural forms. These findings could help to investigate new complement drugs for regulation using arenicin derivatives.

28 September 2022 in Marine Drugs
Verified
Journal Article
Open access
PDF file
IKIlia A. Krenev
Ilia A. Krenev
PPPavel Panteleev
Pavel Panteleev
EUEkaterina S. Umnyakova
Ekaterina S. Umnyakova
NGNikolay Gorbunov
Nikolay Gorbunov
VKValeria Kostevich
Valeria Kostevich
Mikhail BerlovMikhail Berlov
Mikhail Berlov
The widespread resistance to antibiotics in pathogenic bacteria makes the development of a new generation of antimicrobials an urgent task. The development of new antibiotics must be accompanied by a comprehensive study of all of their biological activities in order to avoid adverse side-effects from their application. Some promising antibiotic prototypes derived from the structures of arenicins, antimicrobial peptides from the lugworm Arenicola marina, have been developed. Previously, we described the ability of natural arenicins -1 and -2 to modulate the human complement system activation in vitro. In this regard, it seems important to evaluate the effect of therapeutically promising arenicin analogues on complement activation. Here, we describe the complement-modulating activity of three such analogues, Ar-1[V8R], ALP1, and AA139. We found that the mode of action of Ar-1[V8R] and ALP1 on the complement was similar to that of natural arenicins, which can both activate and inhibit the complement, depending on the concentration. However, Ar-1[V8R] behaved predominantly as an inhibitor, showing only a moderate increase in C3a production in the alternative pathway model and no enhancement at all of the classical pathway of complement activation. In contrast, the action of ALP1 was characterized by a marked increase in the complement activation through the classical pathway in the concentration range of 2.5–20 μg/mL. At the same time, at higher concentrations (80–160 μg/mL), this peptide exhibited a complement inhibitory effect characteristic of the other arenicins. Peptide AA139, like other arenicins, exhibited an inhibitory effect on complement at a concentration of 160 μg/mL, but was much less pronounced. Overall, our results suggest that the effect on the complement system should be taken into account in the development of antibiotics based on arenicins.


1 May 2021 in Russian Journal of Bioorganic Chemistry
Verified
Journal Article
Closed access
PDF file
VPV. A. Pozolotin
V. A. Pozolotin
EUE. S. Umnyakova
E. S. Umnyakova
PKP. M. Kopeykin
P. M. Kopeykin
AKA. S. Komlev
A. S. Komlev
YDY. A. Dubrovskii
Y. A. Dubrovskii
Mikhail BerlovMikhail Berlov
Mikhail Berlov
The complement system plays an important role in the protection of the organism from infection. A key step in complement activation is the proteolytic cleavage of C3 protein resulting in a soluble anaphylatoxin C3a peptide and C3b protein that is able to form a covalent bond with surface molecules of microbial cells. The activity of C3b is regulated by its subsequent limited proteolysis with the release of the C3f peptide, which is believed to have no functional activity itself. Based on the physicochemical properties of C3f, we hypothesized that this peptide may exhibit antimicrobial activity. Complement activation usually takes place on the surface of pathogens, in particular, bacterial cells, and local generation of antimicrobial peptides can contribute significantly to their neutralization. The antimicrobial activity of complement derivatives, C3a and C4a peptides, is already known from the literature. To study the antimicrobial properties of C3f, we obtained this peptide by the method of solid-phase synthesis. It has been shown that human C3f exhibits moderate antimicrobial activity in vitro against certain gram-positive bacteria (Listeria monocytogenes, Micrococcus luteus, Enterococcus faecium) with minimal inhibitory concentrations of 70 μM (for L. monocytogenes) or higher. The revealed antimicrobial activity of C3f is much lower than the activity of C3a described in the literature. Several microorganisms (Bacillus cereus, Escherichia coli, Candida albicans) were resistant to C3f.

25 August 2023 in Medical academic journal
Verified
Journal Article
Open access
PDF file
EEEkaterina V. Egorova
Ekaterina V. Egorova
IKIlia A. Krenev
Ilia A. Krenev
NONikita N. Oborin
Nikita N. Oborin
Mikhail BerlovMikhail Berlov
Mikhail Berlov
The complement system plays a key role in homeostasis and defense against pathogens. The antimicrobial activity of serum against Gram-negative bacteria is usually attributed to the action of the membrane attack complex. However, there is increasing evidence that some other components of the complement system and the products of its activation are also capable of direct killing of both Gram-negative and Gram-positive bacteria. In the course of complement activation, anaphylatoxins C3a, C4a, C5a are produced, which, in addition to their main function, can exhibit a bactericidal effect and disrupt the bacterial membrane. Recent studies have shown that in fish, complement factors D, I, as well as a Ba fragment of factor B, are able to neutralize pathogens. The triggering and amplification of complement usually occurs on the surface of pathogen cells, so the local production of antimicrobial components can potentially make a significant contribution to their elimination. The aim of this review is to outline the role of individual complement members in the elimination of pathogens through direct antibiotic action. The problem of antimicrobial protection in the context of therapeutic complement inhibition is considered.